Literature DB >> 17507868

[Proteus bacilli: features and virulence factors].

Antoni Rózalski1, Iwona Kwil, Agnieszka Torzewska, Magdalena Baranowska, Paweł Staczek.   

Abstract

In this article, different aspects of virulence factors of Proteus bacilii (P. mirabilis, P. vulgaris, P. penneri i P. hauseri) are presented. These are opportunistic pathogens that cause different kinds of infections, most frequently of the urinary tract. These bacteria have developed several virulence factors, such as adherence due to the presence of fimbriae or afimbrial adhesins, invasiveness, swarming phenomenon, hemolytic activity, urea hydrolysis, proteolysis, and endotoxicity. Below we focus on data concerning the molecular basis of the pathogenicity of Proteus bacilli.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507868

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  11 in total

1.  Structural basis for the broad specificity of a new family of amino-acid racemases.

Authors:  Akbar Espaillat; César Carrasco-López; Noelia Bernardo-García; Natalia Pietrosemoli; Lisandro H Otero; Laura Álvarez; Miguel A de Pedro; Florencio Pazos; Brigid M Davis; Matthew K Waldor; Juan A Hermoso; Felipe Cava
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-12-24

2.  The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.

Authors:  Joanna Kwiecińska-Piróg; Krzysztof Skowron; Katarzyna Zniszczol; Eugenia Gospodarek
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

3.  The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains.

Authors:  Joanna Kwiecinska-Pirog; Krzysztof Skowron; Wojciech Bartczak; Eugenia Gospodarek-Komkowska
Journal:  Jundishapur J Microbiol       Date:  2016-04-23       Impact factor: 0.747

4.  Vitamin C in the Presence of Sub-Inhibitory Concentration of Aminoglycosides and Fluoroquinolones Alters Proteus mirabilis Biofilm Inhibitory Rate.

Authors:  Joanna Kwiecińska-Piróg; Krzysztof Skowron; Tomasz Bogiel; Agata Białucha; Jana Przekwas; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2019-08-11

5.  Primary and Secondary Bacteremia Caused by Proteus spp.: Epidemiology, Strains Susceptibility and Biofilm Formation.

Authors:  Joanna Kwiecińska-Piróg; Krzysztof Skowron; Eugenia Gospodarek-Komkowska
Journal:  Pol J Microbiol       Date:  2018

6.  Cloacal Gram-Negative Microbiota in Free-Living Grass Snake Natrix natrix from Poland.

Authors:  Aleksandra Pawlak; Katarzyna Morka; Stanisław Bury; Zuzanna Antoniewicz; Anna Wzorek; Gabriela Cieniuch; Agnieszka Korzeniowska-Kowal; Mariusz Cichoń; Gabriela Bugla-Płoskońska
Journal:  Curr Microbiol       Date:  2020-05-19       Impact factor: 2.188

7.  Isolation, identification & characterization of Proteus penneri--a missed rare pathogen.

Authors:  Janak Kishore
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

Review 8.  Bacterial urease and its role in long-lasting human diseases.

Authors:  Iwona Konieczna; Paulina Zarnowiec; Marek Kwinkowski; Beata Kolesinska; Justyna Fraczyk; Zbigniew Kaminski; Wieslaw Kaca
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

9.  Proteus mirabilis biofilm - qualitative and quantitative colorimetric methods-based evaluation.

Authors:  Joanna Kwiecinska-Piróg; Tomasz Bogiel; Krzysztof Skowron; Ewa Wieckowska; Eugenia Gospodarek
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

10.  Changes in the lipopolysaccharide of Proteus mirabilis 9B-m (O11a) clinical strain in response to planktonic or biofilm type of growth.

Authors:  Agnieszka Zabłotni; Dominik Matusiak; Nikolay P Arbatsky; Magdalena Moryl; Anna Maciejewska; Anna N Kondakova; Alexander S Shashkov; Czesław Ługowski; Yuriy A Knirel; Antoni Różalski
Journal:  Med Microbiol Immunol       Date:  2018-01-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.